Publication & Citation Trends
Publications
80 total
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy PDF
Cited by 383
OpenAlex
Research Topics
Diabetes Treatment and Management
(58)
Chronic Kidney Disease and Diabetes
(25)
Pancreatic function and diabetes
(24)
Diabetes Management and Research
(16)
Metabolism, Diabetes, and Cancer
(15)
Affiliations
AstraZeneca (United Kingdom)
Reykjavík University
University Medical Center Groningen
Sahlgrenska University Hospital
Gentofte Hospital